Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
About Vitamin B12 Individuals who do not consume animal products or have poor natural absorption may have a vitamin B12 deficiency resulting in fatigue, poor sleep, and low concentration
Phase Cag introduction Weeks 9-12 Tirzepatide 5.0 mg/week (hold) Cagrilintide 0.25 mg/week Notes Add cagrilintide at the lowest dose
Rho's products are formulated to work synergistically
Dihexa: Single, targeted synaptogenic hammer
Increase your intake of methylation nutrients The methylation nutrients include vitamins B6, B9, B12, and folate
